halia - dofaq.co
Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics
PR Newswire - 31 Jan 2024
Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics ...
Halia Therapeutics begins trial of HT-6184 for pain management
Clinical Trials Arena - 16 Feb 2024
Halia Therapeutics begins trial of HT-6184 for pain management ...
Ta-Halia Fairman - Track & Field
Charlotte Athletics - 21 Sep 2023
Ta-Halia Fairman - Track & Field ...
Wilson Sonsini Advises Halia Therapeutics on $30 Million Series C Financing
Wilson Sonsini - 06 Feb 2024
Wilson Sonsini Advises Halia Therapeutics on $30 Million Series C Financing ...
How David J. Bearss co-founded Halia Therapeutics - Utah Business
Utah Business - 07 Dec 2023
How David J. Bearss co-founded Halia Therapeutics - Utah Business ...
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics
BioSpace - 04 Jan 2024
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics ...
Halia Therapeutics Completes $30M Series C Financing
Contract Pharma - 31 Jan 2024
Halia Therapeutics Completes $30M Series C Financing ...
Halia Therapeutics to Present at Asia BIO 2024
PR Newswire - 17 Apr 2024
Halia Therapeutics to Present at Asia BIO 2024 ...
Halia Therapeutics opens Lehi lab, hopes to test new dementia drug within a year
Daily Herald - 18 Sep 2023
Halia Therapeutics opens Lehi lab, hopes to test new dementia drug within a year ...
Halia Therapeutics to test HT-6184 in MDS patients for first time
Clinical Trials Arena - 08 Dec 2023
Halia Therapeutics to test HT-6184 in MDS patients for first time ...
Ta-Halia Fairman Earns Women's Track Athlete of the Week Honors
Charlotte Athletics - 30 Jan 2024
Ta-Halia Fairman Earns Women's Track Athlete of the Week Honors ...
Halia Therapeutics to Present at 2024 BIO CEO & Investor Conference
PR Newswire - 21 Feb 2024
Halia Therapeutics to Present at 2024 BIO CEO & Investor Conference ...
Halia Therapeutics to Present at BIO-Europe Spring 2024 Conference
PR Newswire - 12 Mar 2024
Halia Therapeutics to Present at BIO-Europe Spring 2024 Conference ...
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome ...
PR Newswire - 29 Nov 2023
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome ... ...
Halia Therapeutics to Present at the 17th Annual Pain Therapeutics Summit
PR Newswire - 18 Oct 2023
Halia Therapeutics to Present at the 17th Annual Pain Therapeutics Summit ...
Halia Therapeutics to Present New Preclinical Data at the 65th American Society of Hematology (ASH) Annual Meeting ...
PR Newswire - 27 Nov 2023
Halia Therapeutics to Present New Preclinical Data at the 65th American Society of Hematology (ASH) Annual Meeting ... ...
Halia Therapeutics to Attend the 42nd JP Morgan Healthcare Conference and Present at Biotech Showcase in San ...
PR Newswire - 04 Jan 2024
Halia Therapeutics to Attend the 42nd JP Morgan Healthcare Conference and Present at Biotech Showcase in San ... ...
Halia Therapeutics Appoints Former Amgen Scientists, Lisa Shamon, Ph.D., as Vice President of Regulatory Affairs and ...
PR Newswire - 16 Nov 2023
Halia Therapeutics Appoints Former Amgen Scientists, Lisa Shamon, Ph.D., as Vice President of Regulatory Affairs and ... ...
Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business ...
PR Newswire - 31 Oct 2023
Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business ... ...